However, a meta-analysis involving 1836 NPC patients from 15 studies on PD-L1 expression suggested that the expression level of PD-L1 may not be a reliable prognostic biomarker for NPC [36]. The gene discussed is CD274; the disease is nasopharyngeal carcinoma.